Meridian Bioscience Inc Revenue per Employee (VIVO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Meridian Bioscience Inc   (NASDAQ: VIVO)
 

Meridian Bioscience Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Meridian Bioscience Inc 's Revenue per employee fell on a trailing twelve month basis to $ 354,799, but the productivity of Meridian Bioscience Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 114 other companies have achieved higher revenue per employee. While Meridian Bioscience Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 1425. Meridian Bioscience Inc has 850 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VIVO Revenue per Employee (Dec 31 2022)
I. Quarter		 (Sep 30 2022)
IV. Quarter		 (Jun 30 2022)
III. Quarter		 (Mar 31 2022)
II. Quarter		 (Dec 31 2021)
I. Quarter
Y / Y Revenue Change -35.59 % -13.82 % 6.71 % 30.45 % -4.92 %
Sales per Employee (TTM) $ 354,799 391,786 404,173 399,161 368,612
VIVO's Total Ranking # 1425 # 0 # 0 # 0 # 0
Seq. Revenue Change -13.36 % -3.09 % -39.07 % 25.91 % 15.93 %

VIVO Company Profile >> Back to VIVO Efficiency Comparisons >> Compare VIVO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 23
Healthcare Sector # 115
Overall Market # 1425

Revenue per Employee Statistics
High Average Low
$ 404,173 $ 268,868 $ 217,080
(Jun 30 2022)   (Dec 31 2013)



Financial Statements
Meridian Bioscience Inc 's Revenue MRQ $ 57 Millions Visit VIVO's Income Statement
Meridian Bioscience Inc 's Revenues TTM $ 302 Millions Visit VIVO's aggregate revenue growth
What are VIVO's Sales? Visit VIVO's Sales by Segment




Other Ratios
Meridian Bioscience Inc 's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VIVO's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VIVO's Competitors
Revenue per Employee for VIVO's Suppliers
Revenue per Employee for VIVO's Customers

You may also want to know
VIVO's Sales Growth Rates VIVO's Pe Price to earnings ratio VIVO's Receivables Turnover Ratio VIVO's Stock Quote
VIVO's Net Income Growth Rates VIVO's Ps Price to Sales ratio VIVO's Sales per Employee VIVO's Asset Turnover Ratio
VIVO's Net Margin VIVO's Pb Price to Book ratio VIVO's Financial Strength Ratios VIVO's Dividend Payout Ratio
Date modified: 2026-09-08T15:10:48+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2022, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2022Number of Employees Dec 31 2022
Organon and Co   617,400.00 $ 6,174.000  Million 10,000 
Neptune Wellness Solutions Inc   611,765.09 $ 52.000  Million 85 
Morphosys Ag  609,900.28 $ 311.659  Million 511 
Embecta Corp   603,189.19 $ 1,115.900  Million 1,850 
Kiniksa Pharmaceuticals International Plc  601,584.70 $ 220.180  Million 366 
Iridex Corp  601,064.52 $ 55.899  Million 93 
Fate Therapeutics Inc   598,136.65 $ 96.300  Million 161 
Skinhealth Systems Inc   596,861.34 $ 365.876  Million 613 
Sigilon Therapeutics Inc   588,363.64 $ 12.944  Million 22 
Milestone Scientific Inc   587,060.40 $ 8.806  Million 15 
Cutera Inc   586,974.42 $ 252.399  Million 430 
Healthlynked Corp  585,820.20 $ 5.858  Million 10 
Evofem Biosciences Inc   580,586.21 $ 16.837  Million 29 
Bionexus Gene Lab Corp   575,195.11 $ 10.929  Million 19 
Lftd Partners Inc   574,165.35 $ 57.417  Million 100 
Sinovac Biotech Ltd  573,697.54 $ 1,492.761  Million 2,602 
Ascendis Pharma A  573,148.80 $ 57.315  Million 100 
Agile Therapeutics Inc  572,842.11 $ 10.884  Million 19 
Eli Lilly And Company  570,828.00 $ 28,541.400  Million 50,000 
Theravance Biopharma inc   570,511.11 $ 51.346  Million 90 
3m Company  565,768.60 $ 34,229.000  Million 60,500 
Emmaus Life Sciences Inc   557,272.73 $ 18.390  Million 33 
Zoetis Inc   557,241.38 $ 8,080.000  Million 14,500 
Avantor Inc   556,474.07 $ 7,512.400  Million 13,500 
Dyadic International Inc   556,375.20 $ 2.782  Million 5 
Ngm Biopharmaceuticals Inc   553,330.00 $ 55.333  Million 100 
Thermogenesis Holdings Inc   551,736.84 $ 10.483  Million 19 
Corcept Therapeutics Inc  550,490.41 $ 401.858  Million 730 
Perrigo Company Plc  549,382.72 $ 4,450.000  Million 8,100 
Avalo Therapeutics Inc   547,000.00 $ 18.051  Million 33 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.